| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 310 | - | - | 968 | 897 | 1.052 | 2.220 | 5.809 | 8.941 | 9.808 |
| Total Income - EUR | 310 | - | - | 968 | 897 | 1.052 | 2.220 | 5.809 | 8.941 | 9.808 |
| Total Expenses - EUR | 58 | - | - | 661 | 894 | 1.172 | 1.547 | 1.803 | 5.717 | 6.653 |
| Gross Profit/Loss - EUR | 253 | - | - | 307 | 3 | -119 | 673 | 4.006 | 3.223 | 3.155 |
| Net Profit/Loss - EUR | 243 | - | - | 278 | -24 | -151 | 606 | 3.831 | 2.600 | 2.650 |
| Employees | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Medclar Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 104 | - | - | 1.407 | 1.025 | 659 | 305 | 212 | 888 | 495 |
| Current Assets | 1.282 | - | - | 552 | 877 | 1.100 | 3.097 | 4.529 | 6.119 | 9.449 |
| Inventories | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | - | - | 41 | 71 | 46 | 437 | 96 | 42 | 929 |
| Cash | 1.282 | - | - | 511 | 806 | 1.055 | 2.660 | 4.433 | 6.077 | 8.520 |
| Shareholders Funds | 288 | - | - | 454 | 421 | 262 | 863 | 4.697 | 7.282 | 9.892 |
| Social Capital | 45 | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.097 | - | - | 1.504 | 1.482 | 1.497 | 2.539 | 44 | -276 | 52 |
| Income in Advance | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medclar Srl